4th Quarter - Report

THE GIBSON GROUP, LLC for ENDO PHARMACEUTICALS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to incentives for life sciences research. H.R. 160: Protect Medical Innovation Act of 2015.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 160 (114th)

Copyright/Patent/Trademark CPT

Oversight of implementation of the America Invents Act. Issues relating to patent settlements. H.R. 9: The Innovation Act. S. 1137: Protecting American Talent and Entrepreneurship Act of 2015 (PATENT Act). Issues relating to misuse of the inter pares review process.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th), S. 1137 (114th)

Health Issues HCR

Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Compounding and drug supply chain legislation. H.R. 471/S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015. Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 483 (114th), H.R. 471 (114th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.